✦ LIBER ✦

Metastatic hepatocellular carcinoma in the esophagus following liver transplantation

✍ Scribed by Li-Yi Xie; Min Fan; Jia Fan; Jian Wang; Xuan-Li Xu; Guo-Liang Jiang

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 205 KB
Volume: 14
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21546

No coin nor oath required. For personal study only.

✦ Synopsis

We report here a case of post-orthotopic liver transplantation (OLT) hepatocellular carcinoma (HCC) metastasizing to the esophagus. To the best of our knowledge, this is the ninth case of liver carcinoma metastasizing to the esophagus and the first after OLT.

📜 SIMILAR VOLUMES

Sirolimus-based immunosuppression follow

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

✍ Michael A. Zimmerman; James F. Trotter; Michael Wachs; Tom Bak; Jeffrey Campsen; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Experience with sirolimus (SRL)-based immunosuppression following orthotopic liver transplantation (OLT) is rapidly accumulating. In combination with calcineurin inhibitors (CNIs), SRL may reduce the incidence of acute rejection and lower overall required drug levels. This study sought to quantify l

Hepatocellular carcinoma in the setting

Hepatocellular carcinoma in the setting of liver transplantation

✍ Maria Varela; William Sanchez; Jordi Bruix; Gregory J. Gores 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 1 views

Hepatocellular carcinoma (HCC) is a frequent complication and leading cause of mortality among patients with cirrhosis. In the setting of advanced liver disease, many patients with HCC are not candidates for hepatic resection due to inadequate functional hepatic reserve and the risk of postoperative

Liver transplantation in patients with h

Liver transplantation in patients with hepatocellular carcinoma

✍ Myron Schwartz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma: The MELD impact

✍ Pratima Sharma; Vijayan Balan; Jose L. Hernandez; Ann M. Harper; Erick B. Edward 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

The new allocation policy of the United Network of Organ Sharing (UNOS) based on the model for end-stage liver disease (MELD) gives candidates with stage T1 or stage T2 hepatocellular carcinoma (HCC) a priority MELD score beyond their degree of hepatic decompensation. The aim of this study was to de

Preoperative hepatic artery chemoemboliz

Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma

✍ Harnois, Denise M. ;Steers, Jeffery ;Andrews, James C. ;Rubin, Joseph C. ;Pitot, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 111 KB

In our experience, the primary obstacle precluding the widespread use of orthotopic liver transplantation (OLT) for definitive therapy of hepatocellular carcinoma (HCC), even for early-stage disease, is preventing tumor recurrence. Chemoembolization is an attractive strategy to minimize tumor progre

Place of liver transplantation in the tr

Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver

✍ Jan Lerut; Hynek Mergental; Delawir Kahn; Luiz Albuquerque; Juan Marrero; Jean N 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Hepatocellular carcinoma (HCC) is a relatively common cancer and occurs mainly in patients with liver cirrhosis (85%-95%). A significant number of cases are, however, diagnosed in normal and noncirrhotic/nonfibrotic livers. In contrast to HCC in a cirrhotic liver, noncirrhotic hepatocellular carcino